Xencor Q4 EPS $(0.20) Beats $(0.79) Estimate, Sales $21.61M Beat $20.06M Estimate

Xencor (NASDAQ:XNCR) reported quarterly losses of $(0.20) per share which beat the analyst consensus estimate of $(0.79) by 74.68 percent. This is a 116.53 percent decrease over earnings of $1.21 per share from the same

Xencor (NASDAQ:XNCR) reported quarterly losses of $(0.20) per share which beat the analyst consensus estimate of $(0.79) by 74.68 percent. This is a 116.53 percent decrease over earnings of $1.21 per share from the same period last year. The company reported quarterly sales of $21.61 million which beat the analyst consensus estimate of $20.06 million by 7.73 percent. This is a 85.97 percent decrease over sales of $154.02 million the same period last year.

Total
0
Shares
Related Posts
Read More

Biden’s Urgent Action Against Antibiotic-Resistant Bacteria – Allocates $100M to Battle Deadly Superbugs

U.S. President Joe Biden is set to unveil a $100 million research initiative to tackle the growing threat of drug-resistant bacteria.  More than a million people worldwide succumb to infections caused by antibiotic-resistant bacteria annually, as reported by the World Health Organization. 

AMD